2-quinolines series (DNDi/CDRI/Advinus Therapeutics)
N/A
Report date: 2025/02/01 20:00:06
NME
Base Information
Drug Name2-quinolines series (DNDi/CDRI/Advinus Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDrugs For Neglected Diseases Initiative
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesEurofins Advinus LtdCentral Drug Research InstituteDrugs For Neglected Diseases Initiative
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A